Macrocyclic compounds and uses thereof
US11286264B2 · kind B2 · utility
2Cited by
10References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2018 |
| Grant date | Mar 29, 2022 |
| Priority date | — |
| Expiry date | Oct 23, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.